Koaⁿ tōng-me̍h sng-sek su̍t

Kuann tōng-me̍h sng-sik su̍t
Other names	HAE, trans-arterial embolization, TAE
Specialty	interventional radiology/oncology
	[edit on Wikidata]

Kuann tōng-me̍h sng-sik su̍t (ing-gú: Hepatic artery embolization; hàn-gú: 肝動脈栓塞術; Kuann tōng-me̍h sng-sat su̍t), mā kiò-tsò king-iû kuann tōng-me̍h sng-sik su̍t (trans-arterial embolization (TAE)), sī tī-liâu guân-huat-sìng kuann-tsōng tsíng-liû hi̍k-tsiá kuann-tsōng tsíng-liû tsuán-î [en] ê kui-tsióng tī-liâu hong-huat tsi-it. Sng-sik [en] tī-liâu ē-tàng sok-sió tsíng-liû ê tuā-sè; pīng-tshiánn kiám-tsió tsíng-liû tuì ki̍k-sòo sán-sing ê íng-hióng, ū-hāu kiám-khin tsìng-tsōng; tsit-ê liâu-huat siōng-thâu-á khai-huat tī 20 sè-kí 70 nî-tāi tshoo-kî.^[1] Kuí-ā tsióng luī-hîng ê kuann tōng-me̍h tī-liâu khiā tī í-hā ê kuan-tshat: tsíng-liû sè-pau tsha-put-to uì kuann tōng-me̍h tit-tshú sóo-ū ê îng-ióng; lî-tshiánn tsìng-siông ê kuann sè-pau uì kuann tōng-me̍h tit-tshú tāi-iok 70-80% ê îng-ióng hām 50% ê sàng-sòo kiong-ìng tsīng-me̍h. In-tshú ē-sái teh kuann tōng-me̍h ū-hāu tsóo-tn̄g ê tsîng-hóng sing-tsûn.^[2] Teh si̍t-tsiān tang-tiong, kuann tōng-me̍h sng-sik tsóo-tn̄g lâu-uì tsíng-liû ê hiat-liû,^[3] tì-sú tshiau-kuè 80% ê lâng in-ê tsíng-liû hián-tù sok-sió.^[3] Siu-sok lu̍t ta̍k ê lâng lóng bô sio-kâng.^[4]^[5]

Tsù-káis

↑ Del Prete, Michela; Fiore, Francesco; Modica, Roberta; Marotta, Vincenzo; Marciello, Francesca; Ramundo, Valeria; Di Sarno, Antonella; Carratù, Annachiara; Di Roseto, Chiara; Tafuto, Salvatore; Tatangelo, Fabiana; Baldelli, Robero; Colao, Annamaria; Faggiano, Antongiulio (2014). "Hepatic arterial embolization in patients with neuroendocrine tumors". Journal of Experimental & Clinical Cancer Research. 33 (1): 43. doi:10.1186/1756-9966-33-43. PMC 4038067  . PMID 24887262.
↑ Pommier R. 2003. The role of surgery and chemoembolization in the management of carcinoid. California Carcinoid Fighters Conference. October 25, http://www.carcinoid.org/content/role-surgery-and-chemoembolization-management-carcinoid
↑ ^3.0 ^3.1 Kvols LK. 2002. Carcinoid Tumors and the Carcinoid Syndrome: What's New in the Therapeutic Pipeline. (The Carcinoid Cancer Foundation: Carcinoid Symposium 2002)http://www.carcinoid.org/content/carcinoid-tumors-and-carcinoid-syndrome-whats-new-therapeutic-pipeline
↑ Gu, Ping; Wu, Jennifer; Newman, Elliot; Muggia, Franco (2012). "Treatment of Liver Metastases in Patients with Neuroendocrine Tumors of Gastroesophageal and Pancreatic Origin". International Journal of Hepatology. 2012: 1–8. doi:10.1155/2012/131659. PMC 3299245  . PMID 22518318.
↑ Lewis, M. A; Jaramillo, S; Roberts, L; Fleming, C. J; Rubin, J; Grothey, A (2012). "Hepatic Artery Embolization for Neuroendocrine Tumors: Postprocedural Management and Complications". The Oncologist. 17 (5): 725–31. doi:10.1634/theoncologist.2011-0372. PMC 3360912  . PMID 22511263.

Tsham-ua̍t

Neuroendocrine tumor
Carcinoid syndrome
Sng-sik su̍t (Embolization)
Uán-tuann tsuán-î (Metastasis)

Guā-pōo liân-kiat

eMedicine: Embolization
Embolization therapy for liver cancer Archived 2016-11-23 at the Wayback Machine.

[DelPrete2014-1] Del Prete, Michela; Fiore, Francesco; Modica, Roberta; Marotta, Vincenzo; Marciello, Francesca; Ramundo, Valeria; Di Sarno, Antonella; Carratù, Annachiara; Di Roseto, Chiara; Tafuto, Salvatore; Tatangelo, Fabiana; Baldelli, Robero; Colao, Annamaria; Faggiano, Antongiulio (2014). "Hepatic arterial embolization in patients with neuroendocrine tumors". Journal of Experimental & Clinical Cancer Research. 33 (1): 43. doi:10.1186/1756-9966-33-43. PMC 4038067  . PMID 24887262.

[Pommier2003-2] Pommier R. 2003. The role of surgery and chemoembolization in the management of carcinoid. California Carcinoid Fighters Conference. October 25, http://www.carcinoid.org/content/role-surgery-and-chemoembolization-management-carcinoid

[Kvols-3] 3.0 ^3.1 Kvols LK. 2002. Carcinoid Tumors and the Carcinoid Syndrome: What's New in the Therapeutic Pipeline. (The Carcinoid Cancer Foundation: Carcinoid Symposium 2002)http://www.carcinoid.org/content/carcinoid-tumors-and-carcinoid-syndrome-whats-new-therapeutic-pipeline

[Gu2012-4] Gu, Ping; Wu, Jennifer; Newman, Elliot; Muggia, Franco (2012). "Treatment of Liver Metastases in Patients with Neuroendocrine Tumors of Gastroesophageal and Pancreatic Origin". International Journal of Hepatology. 2012: 1–8. doi:10.1155/2012/131659. PMC 3299245  . PMID 22518318.

[Lewis2012-5] Lewis, M. A; Jaramillo, S; Roberts, L; Fleming, C. J; Rubin, J; Grothey, A (2012). "Hepatic Artery Embolization for Neuroendocrine Tumors: Postprocedural Management and Complications". The Oncologist. 17 (5): 725–31. doi:10.1634/theoncologist.2011-0372. PMC 3360912  . PMID 22511263.

[1]

[2]

[3]

[4]

[5]